Xenon Pharmaceuticals XENE
$ 40.2
2.19%
Quarterly report 2024-Q3
added 11-12-2024
Xenon Pharmaceuticals Cash Flow 2011-2024 | XENE
Annual Cash Flow Xenon Pharmaceuticals
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-145 M | -98.4 M | -69.5 M | -48.1 M | -4.71 M | -34.7 M | -28.7 M | - | - | - | - | - | - |
Depreciation & Amortization |
3.54 M | 1.62 M | 906 K | 644 K | 429 K | 586 K | 649 K | 864 K | 1.04 M | 738 K | 705 K | 786 K | - |
Accounts Payables |
8.6 M | 8.49 M | 3.82 M | 3.04 M | 2.47 M | 665 K | 1.25 M | 1.46 M | 1.09 M | 553 K | - | - | - |
Accounts Receivables |
874 K | 986 K | 2.76 M | 1.82 M | 813 K | 256 K | 438 K | 200 K | 315 K | 215 K | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Xenon Pharmaceuticals
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | -43.2 M | - | - | - | -34.4 M | - | -65.7 M | -35.3 M | -18.4 M | - | -48.8 M | -33.8 M | -20.7 M | - | -35 M | -23.9 M | -13.1 M | - | -24.5 M | -17.4 M | -8.7 M | - | -27.5 M | -13.8 M | -8.22 M | - | -21.9 M | -13.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Depreciation & Amortization |
- | - | 599 K | - | - | - | 354 K | - | 1.11 M | 751 K | 376 K | - | 636 K | 427 K | 196 K | - | 442 K | 271 K | 104 K | - | 283 K | 179 K | 79 K | - | 445 K | 302 K | 150 K | - | 502 K | 334 K | 165 K | - | 698 K | 531 K | 282 K | - | 754 K | 492 K | 207 K | - | 533 K | 350 K | 175 K | - | 531 K | - | - | - | - | - | - | - | - | - | - |
Accounts Payables |
5.42 M | 9.5 M | 6.43 M | 8.6 M | 6.1 M | 12 M | 11.4 M | 8.49 M | 3.08 M | 3.18 M | 1.66 M | 3.82 M | 3.08 M | 3.28 M | 2.13 M | 3.04 M | 3.04 M | 3.04 M | 3.04 M | 2.47 M | 2.47 M | 2.47 M | 2.47 M | 665 K | 665 K | 665 K | 665 K | 1.25 M | 1.25 M | 1.25 M | 1.25 M | 1.46 M | 1.46 M | 1.46 M | 1.46 M | 1.09 M | 1.09 M | 1.09 M | 1.09 M | 553 K | 553 K | 553 K | 553 K | 391 K | 391 K | - | - | - | - | - | - | - | - | - | - |
Accounts Receivables |
938 K | 853 K | 833 K | 874 K | 805 K | 2.12 M | 2.22 M | 986 K | 2.48 M | 2.52 M | 2.92 M | 2.76 M | 3.24 M | 2.92 M | 5.06 M | 1.82 M | 1.82 M | 1.82 M | 1.82 M | 813 K | 813 K | 813 K | 813 K | 151 K | 151 K | 151 K | 151 K | 438 K | 438 K | 438 K | 438 K | 200 K | 200 K | 200 K | 200 K | 315 K | 315 K | 315 K | 315 K | 215 K | 215 K | 215 K | 215 K | 440 K | 440 K | - | - | - | - | - | - | - | - | - | - |
Total Inventories |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency